Daniel Desantis signed Novum Pharmaceutical Research SE's 2024 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
Novum Pharmaceutical Research SE's EIN is 25-1658419.
Download the official 2024 Form 5500 (PDF) for Novum Pharmaceutical Research SE from the U.S. Department of Labor's EFAST2 system.
Download the official 2024 Form 5500 (PDF)Novum Pharmaceutical Research SE's plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).
Holdings are itemized directly on this plan's Schedule of Assets, below.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| ADP, INC. | 13-3036745 | — | RECORD KEEPER | $3K | — |
| ADP BROKER-DEALER | 22-3319984 | — | RECORD KEEPER | $0 | — |
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| MMA SECURITIES | — | NEWYORK, NY | ADVISOR |
| PI | % of plan | |||||
|---|---|---|---|---|---|---|
| [Assets held in registered investment companies (mutual funds)] | Other | — | — | $6.6M | 99.5% | |
| [Assets held in participant loans] | Other | — | — | $31K | 0.5% |
| $0 |
| — |
